Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Non-pregnant women~* Women that did not receive any analgesics or misoprostol in the 24 hours prior to insertion~* Women who delivered only by caesarean section~Exclusion criteria:~* Women with any uterine abnormalities as congenital anomalies, endometrial lesions, adenomyosis, fibroids~* Those with a Category 3 or 4 conditions for intrauterine device insertion according to the WHO Medical Eligibility Criteria for contraceptive use~* Allergy to lidocaine.~* Women refuse to participate in the study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- lidocaine group (Type: EXPERIMENTAL): lidocaine in-situ gel inserted vaginally
- placebo group (Type: PLACEBO_COMPARATOR): placebo gel inserted vaginally

Based on this trial design, predict the completion outcome and termination type (if applicable).